Associate Director Market Access HTA Pricing UK

Job description

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so. Does this inspire you and feel like a fit? Then we would love to have you join us! The Role Help shape market access within Genmab’s developing UK oncology affiliate. The Associate Director will lead UK access plans and own end-to-end development and delivery of HTA submissions for assigned assets and indications, supporting timely and equitable patient access. Working closely with the Head of Market Access and Pricing, the role combines deep clinical and health economic understanding with UK payer expertise to develop scientifically defensible reimbursement submissions and informed pricing recommendations. It offers substantial ownership, direct engagement with UK decision-makers and the opportunity to influence regional and global evidence plans. Key responsibilities UK access strategy and launch planning Develop and deliver market access and HTA strategies for assigned oncology assets, aligned with UK portfolio priorities and global strategy. Lead market access contributions within UK launch and brand teams, translating payer requirements and NHS insights into clear priorities and practical access plans. Identify reimbursement barriers and contribute UK access perspectives to pipeline planning, evidence generation and lifecycle management. HTA submission ownership and delivery Own end-to-end planning, development and delivery of NICE and other relevant UK HTA submissions, from scoping through appraisal and final guidance. Lead development of the integrated UK dossier and reimbursement case, bringing together clinical evidence, economic analyses and NHS insights. Lead cross-functional submission teams and external agencies, managing agreed budgets, deliverables and timelines. Lead engagement with HTA bodies for assigned appraisals, including clarification responses, consultation submissions and committee preparation. Coordinate required scientific and business reviews and approvals, ensuring material issues are resolved or escalated before submission. HTA evidence assessment and value demonstration Critically evaluate survival analyses and extrapolations, considering data maturity, statistical fit, clinical plausibility and external validation. Interrogate economic model structures and assumptions, including treatment-effect duration, subsequent therapies, utilities, costs and uncertainty. Assess comparative evidence, including indirect treatment comparisons, and its implications for the UK reimbursement case. Work with evidence specialists to develop and justify proposed UK base-case assumptions, scenario analyses and responses to appraisal challenges. Define UK evidence requirements and agree supporting deliverables and timelines with regional and global colleagues. Lead preparation of integrated responses to clinical and economic appraisal questions, drawing on specialist contributors to explain and defend the evidence. Pricing, reimbursement and NHS access Develop pricing and reimbursement scenarios and recommendations with the Head of Market Access and Pricing, including the implications of evidence uncertainty. Support payer negotiations and proposed access arrangements within delegated authority, preparing analyses for established pricing and commercial approval processes. Build productive relationships with HTA bodies, NHS stakeholders, payers and clinical experts, working with UK colleagues to support implementation of reimbursement outcomes. Collaboration and capability building Partner across Commercial, Medical, Regulatory, CORE, Global Market Access and Corporate Affairs to deliver UK access priorities. Help establish affiliate market access and HTA capabilities through knowledge sharing and effective ways of working. Ensure activities follow applicable requirements and Genmab policies and approval processes. Experience and qualifications Substantial relevant experience in UK HTA, health economics or market access within biopharma or consultancy. Demonstrated experience leading NICE oncology submissions, including development and defence of clinical and economic arguments. Technical depth to critically evaluate economic models, survival extrapolations and comparative evidence, challenge assumptions constructively and explain methodological choices. Strong understanding of NHS structures, funding pathways and access considerations across the UK nations. Experience influencing cross-functional teams and managing specialist agencies, projects and budgets. Relevant degree or equivalent professional experience. A postgraduate qualification in health economics or a related discipline is desirable. UK oncology launch experience and exposure to pricing or payer negotiations are desirable. Personal capabilities Combines technical depth with strategic judgement; takes ownership; communicates complex evidence clearly; builds collaborative relationships; and manages competing priorities effectively in a developing affiliate. The proposed gross annual base salary range for this position, in the primary location, based on a full time schedule is: GBP80,000.00---120,000.00 The final salary offer will depend on several factors, including your skills, qualifications, and experience. In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives. When you join Genmab, you become a part of a culture that supports your physical, financial, social, and emotional well-being. Our benefits include, but are not limited to: Pension Health insurance and wellness benefits Paid time off Employee support programs Further details on eligibility for compensation and benefits based on the role will be provided during the recruitment process. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X . Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com) . Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term